PharmaNet/i3 Appoints Senior Vice President
News Aug 09, 2012
PharmaNet/i3 has announced that Sarajane Mackenzie has been appointed Senior Vice President, Human Resources to lead the global Human Resources function, including talent engagement, human resources operations, total rewards, and professional development. Ms. Mackenzie will be based in Princeton, NJ.
Ms. Mackenzie has more than thirty years of experience in Human Resources in the pharmaceutical, technology, consumer healthcare, and life sciences industries.
Previously, Ms. Mackenzie served as Vice President, Human Resources for Tata Consultancy Services overseeing the Human Resources function in North America for more than 18,000 employees.
Earlier in her career, Ms. Mackenzie held positions of increasing responsibility at Johnson & Johnson and Novo Nordisk, where she directed international Human Resource activities.
Her experience also includes a complete build of the Human Resources function for an emerging biotechnology company.
“Sarajane brings the expertise and global experience necessary to support a leading international CRO and to assist in its continued growth,” said PharmaNet/i3’s Mike Ivers, Chief Operating Officer.
Ivers continued, “The addition of Sarajane to our senior management team will help us optimize our human resources, enhance professional development opportunities for our employees, and ensure we have the top talent to serve our clients.”
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE